5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate.
A broad spectrum of mutations occurs at a high rate during a single round of retrovirus replication (V.K. Pathak and H. M. Temin, Proc. Natl. Acad. Sci. USA 87:6019-6023, 1990). We have now determined that this high rate of spontaneous mutation can be further increased by 5-azacytidine (AZC) treatment or by regions of potential RNA secondary structure. We found a 13-fold increase in the mutation rate after AZC treatment of retrovirus-producing cells and target cells. The AZC-induced substitutions were located at the same target sites as previously identified spontaneous substitutions. The concordance of the AZC-induced and spontaneous substitutions indicates the presence of reverse transcription "pause sites," where the growing point is error prone. An analysis of nucleotides that neighbored substitutions revealed that transversions occur primarily by transient template misalignment, whereas transitions occur primarily by misincorporation. We also introduced a 34-bp potential stem-loop structure as an in-frame insertion within a lacZ alpha gene that was inserted in the long terminal repeat (LTR) U3 region and determined whether this potential secondary structure increased the rate of retrovirus mutations. We found a threefold increase in the retrovirus mutation rate. Fifty-seven of 96 mutations were deletions associated with the potential stem-loop. We also determined that these deletion mutations occurred primarily during minus-strand DNA synthesis by comparing the frequencies of mutations in recovered provirus plasmids containing both LTRs and in provirus plasmids containing only one LTR.
McArdle Laboratory, Madison, Wisconsin 53706.
V K
VK
Pathak
H M
HM
Temin
D000818:Animals; D001374:Azacitidine / Q000494:pharmacology*; D001483:Base Sequence; D002460:Cell Line; D002874:Chromosome Mapping; D005822:Genetic Vectors; D008969:Molecular Sequence Data; D009154:Mutation / Q000187:drug effects*; D009690:Nucleic Acid Conformation; D011533:Proviruses / Q000235:genetics / Q000302:isolation & purification; D001356:Reticuloendotheliosis virus / Q000235:genetics*; D012190:Retroviridae / Q000235:genetics*; D006377:T-Lymphocytes, Helper-Inducer
D001374:Azacitidine